"Fullerton Neurology and Headache Center is a state-of-the-art medical office, strategically located near St Jude Medical Center, providing comprehensive neurological care. It is fitted with larger exam rooms and an infusion suite, furnished with new equipment and furniture and designed to be to easily accessible. The goal of Fullerton Neurology and Headache Center is to treat every patient with dignity and compassion. We understand that patients may have fears and anxieties about their symptoms."

During the past decade, Fullerton Neurology and Headache Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fullerton Neurology and Headache Center" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Emerald Health Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fullerton Neurology and Headache Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fullerton Neurology and Headache Center" are "Alzheimer Disease" (3 trials), "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Alzheimer Disease (AD)" (1 trials) and "Chronic Migraine" (1 trials). Many other conditions were trialed in "Fullerton Neurology and Headache Center" in a lesser frequency.

Most popular intervention types in "Fullerton Neurology and Headache Center" are "Drug" (14 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Fenebrutinib" (2 trials), "Galcanezumab" (2 trials), "Gantenerumab" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fullerton Neurology and Headache Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Fullerton Neurology and Headache Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fullerton Neurology and Headache Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fullerton Neurology and Headache Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".